Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio

Amir Nasrollahizadeh; Sepide Javankiani; Soheil Rahmati; Ali Nasrollahizadeh; Diaa Hakim; Daniel Modin; Niklas Dyrby Johansen; Tor Biering-Sørensen; Kaveh Hosseini

doi:10.1016/j.ahjo.2026.100718

Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio

Amir Nasrollahizadeh, Sepide Javankiani, Soheil Rahmati, Ali Nasrollahizadeh, Diaa Hakim, Daniel Modin, Niklas Dyrby Johansen, Tor Biering-Sørensen, Kaveh Hosseini^*

^*Corresponding author af dette arbejde

Originalsprog	Engelsk
Artikelnummer	100718
Tidsskrift	American Heart Journal Plus: Cardiology Research and Practice
Vol/bind	63
Antal sider	2
ISSN	2666-6022
DOI	https://doi.org/10.1016/j.ahjo.2026.100718
Status	Udgivet - mar. 2026

Adgang til dokumentet

10.1016/j.ahjo.2026.100718Licens: CC BY-NC-ND

Andre filer og links

Link to publication in Scopus

Citationsformater

Nasrollahizadeh, A., Javankiani, S., Rahmati, S., Nasrollahizadeh, A., Hakim, D., Modin, D., Johansen, N. D., Biering-Sørensen, T., & Hosseini, K. (2026). Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio. American Heart Journal Plus: Cardiology Research and Practice, 63, Artikel 100718. https://doi.org/10.1016/j.ahjo.2026.100718

Nasrollahizadeh, A, Javankiani, S, Rahmati, S, Nasrollahizadeh, A, Hakim, D, Modin, D , Johansen, ND , Biering-Sørensen, T & Hosseini, K 2026, 'Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio', American Heart Journal Plus: Cardiology Research and Practice, bind 63, 100718. https://doi.org/10.1016/j.ahjo.2026.100718

@article{77eb131b3eb04be38287ae5ab7751248,

title = "Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio",

author = "Amir Nasrollahizadeh and Sepide Javankiani and Soheil Rahmati and Ali Nasrollahizadeh and Diaa Hakim and Daniel Modin and Johansen, \{Niklas Dyrby\} and Tor Biering-S{\o}rensen and Kaveh Hosseini",

year = "2026",

month = mar,

doi = "10.1016/j.ahjo.2026.100718",

language = "English",

volume = "63",

journal = "American Heart Journal Plus: Cardiology Research and Practice",

issn = "2666-6022",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Novel insights into SGLT2 inhibitor efficacy in heart failure

T2 - A meta-analysis employing win ratio, hazard ratio, and risk ratio

AU - Nasrollahizadeh, Amir

AU - Javankiani, Sepide

AU - Rahmati, Soheil

AU - Nasrollahizadeh, Ali

AU - Hakim, Diaa

AU - Modin, Daniel

AU - Johansen, Niklas Dyrby

AU - Biering-Sørensen, Tor

AU - Hosseini, Kaveh

PY - 2026/3

Y1 - 2026/3

UR - https://www.scopus.com/pages/publications/105029108679

U2 - 10.1016/j.ahjo.2026.100718

DO - 10.1016/j.ahjo.2026.100718

M3 - Letter

C2 - 41694545

AN - SCOPUS:105029108679

SN - 2666-6022

VL - 63

JO - American Heart Journal Plus: Cardiology Research and Practice

JF - American Heart Journal Plus: Cardiology Research and Practice

M1 - 100718

ER -